When drugs that help turn into drugs that harm

by Carolyn Thomas    @HeartSisters

nutrient-drug-interactions-2129I’ve been thinking an awful lot about drug safety lately, ever since I’ve been camped out at the hospital bedside of a dear friend.  She’s been hospitalized with a severe drug toxicity reaction to a commonly-prescribed medication she’d been newly taking for the past month. And when I say “severe”, I mean you cannot even imagine the horrific symptoms she has suffered day after day after day, week after week, while the pharmaceutical culprit, excruciatingly slowly, clears her system.
Continue reading “When drugs that help turn into drugs that harm”

Women, controversial statin guidelines, and common sense

by Carolyn Thomas  @HeartSisters

101109expIf you’re a heart patient, I’m betting that you’re already taking one of the cholesterol-lowering drugs called statins. That’s because these drugs – with brand names like Lipitor, Crestor, Zocor or any of their generic forms – are routinely prescribed to those diagnosed with cardiovascular disease. Many studies (largely funded by the drug companies that make statins) suggest that, for heart attack survivors, these drugs may help to significantly lower our risk of having another cardiac event. It’s what doctors call “secondary prevention”.

Some studies further suggest that statins are also useful for those who’ve never had heart disease, but who do have high LDL (or “bad”) cholesterol – what’s called “primary prevention”. But recently, statins hit the front page of The New York Times with a big fat *splat* when new clinical practice guidelines for treating/preventing heart disease were released by the American Heart Association and the American College of Cardiology (both heart organizations that are coincidentally largely funded by drug companies, too). The guidelines essentially said: from now on, forget about your LDL numbers. It’s all about your risk factors now. 

The likely result of this change, as I observed here and here, is the recommendation that, as long as you have a detectable pulse, you need to take statins. 

Continue reading “Women, controversial statin guidelines, and common sense”

25 tips to manage the crushing fatigue of heart disease

by Carolyn Thomas   @HeartSisters

For my whole life BHA (Before Heart Attack), I can hardly remember feeling real fatigue. Oh, sure, I’d feel sore working long hot days on our fruit farm as a teenager. Or sleepy after pulling those all-nighters in college. Or out-of-my-mind exhausted coping with a teething baby and a sleepless toddler. Or tired at the end of a stressful day juggling deadlines in my public relations career. Or maybe even pleasantly pooped after my running group finished a long road race. But generally speaking, on a day-to-day basis, never ever the kind of severe fatigue I experienced AHA.

I’ve always  been one of those disgustingly perky early risers who leaped cheerfully out of bed the minute one droopy eyelid cracked open to discover the clock showed anything past 4:30 a.m.  Once I finished leaping, I’d hit the coffeepot and then the shower, in that order. Then away I’d go, tap dancing 90 mph to meet the day ahead, rarely slowing down until I hit the pillow much, much later that night.

But after I was discharged from hospital following my heart attack, I was gobsmacked to suddenly experience daily bouts of extreme bone-crushing fatigue that I could never have even imagined existed before.  Continue reading “25 tips to manage the crushing fatigue of heart disease”

Study: statin drugs overprescribed for healthy adults

by Carolyn Thomas    @HeartSisters

A study from Johns Hopkins Hospital may be very bad news for drug companies that make statin drugs for cholesterol management.(1)  Statins, of course, are considered the darlings of Big Pharma. I’ve heard cardiologists joke (at least, I think they were joking) that statins are so fabulous at lowering our LDL (bad) cholesterol that we should be putting the drugs into our drinking water.

Virtually all heart attack survivors are now routinely prescribed statins (whether they have high cholesterol or not) and there’s a major marketing push for docs to prescribe statins as cardiovascular preventive therapy for virtually all adults, particularly to reduce blood levels of the inflammatory byproducts called C-reactive protein. But the Johns Hopkins study lead investigator Dr. Michael Blaha has this important new warning:   Continue reading “Study: statin drugs overprescribed for healthy adults”